Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1146629-86-8
2. Arry-543
3. Varlitinib Tosilate
4. Varlitinib Tosylate [usan]
5. Arry-543 Ditosilate
6. Arry-334543 Ditosilate
7. Ar00334543 Ditosilate
8. V4m8fws152
9. Ar00334543
10. Varlitinib Tosylate (usan)
11. Unii-v4m8fws152
12. Arry 543
13. Varlitinib Ditosylate
14. Ar 00334543
15. Arry-543 Ditosylate
16. Schembl572691
17. Chembl2105679
18. Arry-334543 Ditosylate
19. Ar00334543 Ditosylate
20. Ex-a4491
21. Mfcd20275100
22. Varlitinib Tosylate [who-dd]
23. N4-[3-chloro-4-(2-thiazolylmethoxy)phenyl]-n6-[(4r)-4,5-dihydro-4-methyl-2-oxazolyl]-4,6-quinazolinediamine Bis(4-methylbenzenesulfonate)
24. D09690
25. Ar00334543 Arry-334543 Arry-543
26. Q27291527
27. 4,6-quinazolinediamine, N4-(3-chloro-4-(2-thiazolylmethoxy)phenyl)-n6-((4r)-4,5-dihydro-4-methyl-2-oxazolyl)-, 4-methylbenzenesulfonate (1:2)
28. 4-n-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-6-n-((4r)-4-methyl-4,5-dihydrooxazol-2- Yl)quinazoline-4,6-diamine Bis(4-methylbenzenesulfonate)
Molecular Weight | 811.4 g/mol |
---|---|
Molecular Formula | C36H35ClN6O8S3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 9 |
Exact Mass | 810.1367033 g/mol |
Monoisotopic Mass | 810.1367033 g/mol |
Topological Polar Surface Area | 247 Ų |
Heavy Atom Count | 54 |
Formal Charge | 0 |
Complexity | 866 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of Varlitinib Tosylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Varlitinib Tosylate manufacturer or Varlitinib Tosylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Varlitinib Tosylate manufacturer or Varlitinib Tosylate supplier.
PharmaCompass also assists you with knowing the Varlitinib Tosylate API Price utilized in the formulation of products. Varlitinib Tosylate API Price is not always fixed or binding as the Varlitinib Tosylate Price is obtained through a variety of data sources. The Varlitinib Tosylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Varlitinib Tosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Varlitinib Tosylate, including repackagers and relabelers. The FDA regulates Varlitinib Tosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Varlitinib Tosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Varlitinib Tosylate supplier is an individual or a company that provides Varlitinib Tosylate active pharmaceutical ingredient (API) or Varlitinib Tosylate finished formulations upon request. The Varlitinib Tosylate suppliers may include Varlitinib Tosylate API manufacturers, exporters, distributors and traders.
Varlitinib Tosylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Varlitinib Tosylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Varlitinib Tosylate GMP manufacturer or Varlitinib Tosylate GMP API supplier for your needs.
A Varlitinib Tosylate CoA (Certificate of Analysis) is a formal document that attests to Varlitinib Tosylate's compliance with Varlitinib Tosylate specifications and serves as a tool for batch-level quality control.
Varlitinib Tosylate CoA mostly includes findings from lab analyses of a specific batch. For each Varlitinib Tosylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Varlitinib Tosylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Varlitinib Tosylate EP), Varlitinib Tosylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Varlitinib Tosylate USP).